Ben Graham prefers companies' interest coverage to be at least 5. Jilin Province Huinan Changlong Bio-pharmacy Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
STU:JIL'
s Interest Coverage Range Over the Past 10 Years
Min: 90.49 Med: 322.4 Max: 2878.22
Current: 154.89
STU:JIL's Interest Coverage is ranked better than 83.33% of 684
companies
in the Drug Manufacturers industry
Industry Median: 12.765
vs STU:JIL: 154.89
Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Jilin Province Huinan Changlong Bio-pharmacy Co Interest Coverage Related Terms
Jilin Province Huinan Changlong Bio-pharmacy Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Jilin Province Huinan Changlong Bio-pharmacy Co Interest Coverage Chart
Jilin Province Huinan Changlong Bio-pharmacy Co Annual Data
STU:JIL vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Jilin Province Huinan Changlong Bio-pharmacy Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jilin Province Huinan Changlong Bio-pharmacy Co Interest Coverage vs Drug Manufacturers Industry
Jilin Province Huinan Changlong Bio-pharmacy Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) has a Interest Coverage of 225.81 as of Dec. 2025. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. This is 30% below median its historical median of 322.40. Over the past decade, Jilin Province Huinan Changlong Bio-pharmacy Co's Interest Coverage has ranged from 90.49 to 2,878.22. According to the industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #114 out of 684 companies in the Drug Manufacturers industry, placing it in the top 16.7%.
Is Jilin Province Huinan Changlong Bio-pharmacy Co's Interest Coverage too high?
Jilin Province Huinan Changlong Bio-pharmacy Co's current Interest Coverage of 225.81 is 30% below median its 10-year median of 322.40. Over the past 10 years, this metric has ranged from a low of 90.49 to a high of 2,878.22. The Drug Manufacturers industry median Interest Coverage is 12.77. Jilin Province Huinan Changlong Bio-pharmacy Co's value of 225.81 is 1669% above this industry median. Based on the distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #114 out of 684 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jilin Province Huinan Changlong Bio-pharmacy Co has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Jilin Province Huinan Changlong Bio-pharmacy Co's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jilin Province Huinan Changlong Bio-pharmacy Co ranks #114 out of 684 companies for Interest Coverage. This places Jilin Province Huinan Changlong Bio-pharmacy Co in the top 17% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.77. Jilin Province Huinan Changlong Bio-pharmacy Co's value of 225.81 is 1669% above this benchmark. Historically, Jilin Province Huinan Changlong Bio-pharmacy Co's own Interest Coverage has ranged from 90.49 to 2,878.22 over the past decade. While the company's 10-year median is 322.40 vs. the industry median of 12.77, Jilin Province Huinan Changlong Bio-pharmacy Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.77, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jilin Province Huinan Changlong Bio-pharmacy Co's current Interest Coverage of 225.81 is 1669% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Jilin Province Huinan Changlong Bio-pharmacy Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.77 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jilin Province Huinan Changlong Bio-pharmacy Co's current Interest Coverage is 225.81, which is 30% below median its own 10-year median of 322.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jilin Province Huinan Changlong Bio-pharmacy Co stock overvalued right now?
Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) has a current Interest Coverage of 225.81. The stock's GF Value™ is €0.18, compared to a current price of €0.25 — trading 37.8% above its estimated fair value. The current Interest Coverage is 225.81, which is 30% below median its 10-year median of 322.40 and 1669% above the Drug Manufacturers industry median of 12.77. Jilin Province Huinan Changlong Bio-pharmacy Co's overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL), the current Interest Coverage is 225.81 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jilin Province Huinan Changlong Bio-pharmacy Co (STU:JIL) Overvalued in 2026?
Based on GuruFocus' analysis, Jilin Province Huinan Changlong Bio-pharmacy Co stock appears to be overvalued.
The current stock price of €0.25 is trading 37.8% above its estimated GF Value™ of €0.18.
Key valuation signals for STU:JIL:
Interest Coverage: 225.81 (30% below median its 10-year median of 322.40)
GF Value™: €0.18 vs. price of €0.25 (37.8% above fair value)
Industry Position: 1669% above the Drug Manufacturers median (#114 of 684)
No single metric tells the full story. See the STU:JIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jilin Province Huinan Changlong Bio-pharmacy Co Business Description
Jilin Province Huinan Changlong Bio-pharmacy Co Ltd is principally engaged in the manufacture and distribution of Chinese medicines and pharmaceutical products in the PRC under the brand names of Changlong and Qing Tong. The company has only one business segment. It generates revenue from the Sales of Chinese medicines and pharmaceutical products. Geographically, it derives its entire revenue from the PRC.
81GF Score
Get the complete analysis for STU:JIL
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:JIL has been successfully added to your 
